It would be nice to see this 3 month slide come to an end. This hasn't stop retreating since a substantial sell off occurred from the the low 8's on decent volume. I recall a poster suggesting at time that that sell off was a good thing. Absolutely amazing!
Perhaps it was Ayer who thought it was a good thing (or me short from $7.81). The phony 100% move up on a 26 M dilution was the - real- "maniuplation"
Valuation of Insmed will be known with news of value,like test results ,not 3 hedge funds who have a Insmed hedge fund manager CEO asking for liquidity.
Target is 4.80, but I may cover at any time.The lack of REAL interest in this company is very poor.
Same old INSM constant pps control. No sellers of any amount a constant drip drip drip on constant low volume. I had hoped that the new team would put an end to this. So we continue to wait. Would appear that new team is not able to get any interested big investors. Perhaps they should stop awarding themselves until they reach some major milestones. You can look forward to this for another few months.